Femoral Artery Atherosclerosis More Common in Psoriasis
The results indicated that participants with psoriasis had a significantly higher prevalence of femoral plaques compared with control patients.
Plaque Psoriasis
Out-of-Pocket Costs Similar for Infliximab, Infliximab-Dyyb
Under Medicare Part D, out-of-pocket costs are similar for infliximab and its biosimilar infliximab-dyyb.
Resubmitted Duobrii Lotion NDA for Plaque Psoriasis Accepted
Its long-term safety was evaluated in a phase 3, multicenter, open-label study of 555 adults with moderate to severe plaque psoriasis.
Ixekizumab Effective for Long-Term Treatment of Plaque Psoriasis
Similar response rates were observed in patients with baseline scalp, nail, or palmoplantar involvement.
New Biologic Treatment Option Approved for Patients With Plaque Psoriasis
The expanded approval was supported by findings from a Phase 3 clinical program (CIMPASI-1, CIMPASI-2, and CIMPACT), which enrolled ~1000 patients who were biologic-naive or biologic-experienced.
Shower Cream, Body Lotion Combo Improves Atopic Dry Skin
A shower cream and a body lotion with physiological lipids are effective in improving skin hydration in patients with dry skin.
High-Dose Certolizumab Pegol Effective for Symptom Reduction in Chronic Plaque Psoriasis
The investigators concluded that both certolizumab pegol treatment regimens improved the symptoms of psoriasis among the participants, with the greatest response observed at the higher dose.
Psoriasis Negatively Affects Patient Sleep Quality
Patients with psoriasis commonly report poor sleep, with itch being the main predictor.
Secukinumab for Severe Psoriasis Relapse After Brodalumab Discontinuation
Investigators sought to determine whether secukinumab is effective for severe forms of plaque psoriasis after an abrupt discontinuation of brodalumab.
Ilumya Approved for Moderate-to-Severe Plaque Psoriasis
The FDA approval of Ilumya for the treatment of adults with moderate-to-severe plaque psoriasis was supported by data from the pivotal Phase-3 reSURFACE clinical development program.
- Loading...
Loading...
Next post in Psoriasis
Loading... 
Loading...